Kudo, M. (2022). Combination Immunotherapy with Anti-PD-1/PD-L1 Antibody plus Anti-VEGF Antibody May Promote Cytotoxic T Lymphocyte Infiltration in Hepatocellular Carcinoma, Including in the Noninflamed Subclass. Karger Publishers.
Chicago Style (17th ed.) CitationKudo, Masatoshi. Combination Immunotherapy with Anti-PD-1/PD-L1 Antibody Plus Anti-VEGF Antibody May Promote Cytotoxic T Lymphocyte Infiltration in Hepatocellular Carcinoma, Including in the Noninflamed Subclass. Karger Publishers, 2022.
MLA (9th ed.) CitationKudo, Masatoshi. Combination Immunotherapy with Anti-PD-1/PD-L1 Antibody Plus Anti-VEGF Antibody May Promote Cytotoxic T Lymphocyte Infiltration in Hepatocellular Carcinoma, Including in the Noninflamed Subclass. Karger Publishers, 2022.
Warning: These citations may not always be 100% accurate.